SEC Form 4 · accession 0001209191-16-138921
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ann Hanham
Director
Period of report
Aug 25, 2016
Accepted (ET)
Aug 29, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.61 | Aug 25, 2016 | A | 10,000 | A | — | Aug 24, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1One-third of the shares will vest twelve months after August 25, 2016 and the remaining shares will vest monthly in equal installments over a two year period such that the stock option is fully vested on the third anniversary of August 25, 2016.